Outset Medical Inc OM.OQ OM.O is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2025
The San Jose California-based company is expected to report a 7.4% increase in revenue to $29.408 million from $27.39 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for Outset Medical Inc is for a loss of 98 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Outset Medical Inc is $23.00, about 34.6% above its last closing price of $15.04
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.92
-0.94
-3.24
Missed
-242.9
Dec. 31 2025
-6.15
-6.19
-5.55
Beat
10.3
Sep. 30 2024
-6.37
-6.33
-5.85
Beat
7.5
Jun. 30 2024
-6.76
-6.78
-7.05
Missed
-4.1
Mar. 31 2024
-8.47
-8.23
-8.55
Missed
-3.9
Dec. 31 2023
-9.20
-9.22
-8.85
Beat
4.1
Sep. 30 2023
-9.98
-10.00
-10.65
Missed
-6.5
Jun. 30 2023
-12.53
-11.44
-13.50
Missed
-18
This summary was machine generated August 4 at 20:22 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)